Literature DB >> 11504927

HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals.

S Moir1, A Malaspina, K M Ogwaro, E T Donoghue, C W Hallahan, L A Ehler, S Liu, J Adelsberger, R Lapointe, P Hwu, M Baseler, J M Orenstein, T W Chun, J A Mican, A S Fauci.   

Abstract

A number of perturbations of B cells has been described in the setting of HIV infection; however, most remain poorly understood. To directly address the effect of HIV replication on B cell function, we investigated the capacity of B cells isolated from HIV-infected patients to respond to a variety of stimuli before and after reduction of viremia by effective antiretroviral therapy. B cells taken from patients with high levels of plasma viremia were defective in their proliferative responses to various stimuli. Viremia was also associated with the appearance of a subpopulation of B cells that expressed reduced levels of CD21. After fractionation into CD21(high)- and CD21(low)-expressing B cells, the CD21(low) fraction showed dramatically reduced proliferation in response to B cell stimuli and enhanced secretion of immunoglobulins when compared with the CD21(high) fraction. Electron microscopic analysis of each fraction revealed cells with plasmacytoid features in the CD21(low) B cell population but not in the CD21(high) fraction. These results indicate that HIV viremia induces the appearance of a subset of B cells whose function is impaired and which may be responsible for the hypergammaglobulinemia associated with HIV disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11504927      PMCID: PMC56966          DOI: 10.1073/pnas.181347898

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Reduced expression of the complement receptor type 2 (CR2, CD21) by synovial fluid B and T lymphocytes.

Authors:  H Illges; M Braun; H H Peter; I Melchers
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

2.  Loss of memory (CD27) B lymphocytes in HIV-1 infection.

Authors:  A De Milito; C Mörch; A Sönnerborg; F Chiodi
Journal:  AIDS       Date:  2001-05-25       Impact factor: 4.177

Review 3.  The molecular basis of acquired immunodeficiency syndrome-related lymphomagenesis.

Authors:  G Gaidano; D Capello; A Carbone
Journal:  Semin Oncol       Date:  2000-08       Impact factor: 4.929

4.  Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus.

Authors:  M Odendahl; A Jacobi; A Hansen; E Feist; F Hiepe; G R Burmester; P E Lipsky; A Radbruch; T Dörner
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

5.  Defective B-lymphocyte function in homosexual men in relation to the acquired immunodeficiency syndrome.

Authors:  S G Pahwa; M T Quilop; M Lange; R N Pahwa; M H Grieco
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

6.  Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody.

Authors:  T F Tedder; L T Clement; M D Cooper
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

7.  B-cell immunodeficiency in acquired immune deficiency syndrome.

Authors:  A J Ammann; G Schiffman; D Abrams; P Volberding; J Ziegler; M Conant
Journal:  JAMA       Date:  1984-03-16       Impact factor: 56.272

8.  Immunoregulatory subsets of the T helper and T suppressor cell populations in homosexual men with chronic unexplained lymphadenopathy.

Authors:  J K Nicholson; J S McDougal; T J Spira; G D Cross; B M Jones; E L Reinherz
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

9.  Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

Authors:  H C Lane; H Masur; L C Edgar; G Whalen; A H Rook; A S Fauci
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

10.  Defective humoral immunity in pediatric acquired immune deficiency syndrome.

Authors:  L J Bernstein; H D Ochs; R J Wedgwood; A Rubinstein
Journal:  J Pediatr       Date:  1985-09       Impact factor: 4.406

View more
  121 in total

Review 1.  Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: risk without reward.

Authors:  Ume L Abbas; John W Mellors
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

2.  Rapid HIV Progression Is Associated with Extensive Ongoing Somatic Hypermutation.

Authors:  Ben S Wendel; Yajing Fu; Chenfeng He; Stefany M Hernandez; Mingjuan Qu; Zining Zhang; Yongjun Jiang; Xiaoxu Han; Junjie Xu; Haibo Ding; Ning Jiang; Hong Shang
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.422

3.  Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors.

Authors:  Lela Kardava; Susan Moir; Wei Wang; Jason Ho; Clarisa M Buckner; Jacqueline G Posada; Marie A O'Shea; Gregg Roby; Jenny Chen; Hae Won Sohn; Tae-Wook Chun; Susan K Pierce; Anthony S Fauci
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

4.  Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals.

Authors:  Tae-Wook Chun; J Shawn Justement; Christina Sanford; Claire W Hallahan; Marie A Planta; Mona Loutfy; Shyam Kottilil; Susan Moir; Colin Kovacs; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

Review 5.  Novel Imaging Methods for Analysis of Tissue Resident Cells in HIV/SIV.

Authors:  Eirini Moysi; Jacob D Estes; Constantinos Petrovas
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

6.  Human immunodeficiency virus type-1 induces a regulatory B cell-like phenotype in vitro.

Authors:  Jacobo Lopez-Abente; Adrián Prieto-Sanchez; Maria-Ángeles Muñoz-Fernandez; Rafael Correa-Rocha; Marjorie Pion
Journal:  Cell Mol Immunol       Date:  2017-07-17       Impact factor: 11.530

7.  Evolution of broadly cross-reactive HIV-1-neutralizing activity: therapy-associated decline, positive association with detectable viremia, and partial restoration of B-cell subpopulations.

Authors:  Carolina B Ferreira; Alberto Merino-Mansilla; Anuska Llano; Ignacio Pérez; Isabel Crespo; Laia Llinas; Felipe Garcia; Jose M Gatell; Eloisa Yuste; Victor Sanchez-Merino
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

8.  Effective B cell activation in vitro during viremic HIV-1 infection with surrogate T cell stimulation.

Authors:  Lindsay K Nicholson; Harsh Pratap; Elisabeth Bowers; Elise Gunzburger; Srinivasa R Bandi; Edward M Gardner; Brent E Palmer; Timothy Wright; John Kittelson; Edward N Janoff
Journal:  Immunobiology       Date:  2018-09-07       Impact factor: 3.144

9.  Alterations in peripheral blood B-cell populations in SHIV89.6P-infected macaques (Macacca fascicularis).

Authors:  Heather M Kling; Timothy W Shipley; Karen A Norris
Journal:  Comp Med       Date:  2011-06       Impact factor: 0.982

10.  Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals.

Authors:  Susan Moir; Kisani M Ogwaro; Angela Malaspina; Joshua Vasquez; Eileen T Donoghue; Claire W Hallahan; Shuying Liu; Linda A Ehler; Marie A Planta; Shyamasundaran Kottilil; Tae-Wook Chun; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.